155 related articles for article (PubMed ID: 36210027)
1. Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation.
Fraint E; Farooki S; Klein E; Mauguen A; Prockop SE; Scaradavou A; Curran K; Cancio M; Spitzer B; Boelens JJ; Oved J; Harris A; O'Reilly RJ; Kernan NA
Transplant Cell Ther; 2023 Jan; 29(1):46.e1-46.e6. PubMed ID: 36210027
[TBL] [Abstract][Full Text] [Related]
2. Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Shahzad M; Siddiqui RS; Anwar I; Chaudhary SG; Ali T; Naseem M; Ahmed TF; Ahmed Z; Khurana S; Ahmed N; Balusu R; Singh AK; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
Transplant Cell Ther; 2021 Oct; 27(10):877.e1-877.e8. PubMed ID: 34284148
[TBL] [Abstract][Full Text] [Related]
3. Fresh or Cryopreserved CD34
Ghobadi A; Fiala MA; Ramsingh G; Gao F; Abboud CN; Stockerl-Goldstein K; Uy GL; Grossman BJ; Westervelt P; DiPersio JF
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1072-1077. PubMed ID: 28323004
[TBL] [Abstract][Full Text] [Related]
4. Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation.
Larocca A; Piaggio G; Podestà M; Pitto A; Bruno B; Di Grazia C; Gualandi F; Occhini D; Raiola AM; Dominietto A; Bregante S; Lamparelli T; Tedone E; Oneto R; Frassoni F; Van Lint MT; Pogliani E; Bacigalupo A
Haematologica; 2006 Jul; 91(7):935-40. PubMed ID: 16818281
[TBL] [Abstract][Full Text] [Related]
5. Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation.
Haen SP; Schumm M; Faul C; Kanz L; Bethge WA; Vogel W
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2241-51. PubMed ID: 26272482
[TBL] [Abstract][Full Text] [Related]
6. Partially mismatched pediatric transplants with allogeneic CD34(+) blood cells from a related donor.
Kawano Y; Takaue Y; Watanabe A; Takeda O; Arai K; Itoh E; Ohno Y; Teshima T; Harada M; Watanabe T; Okamoto Y; Abe T; Kajiume T; Matsushita T; Ikeda K; Endo M; Kuroda Y; Asano S; Tanosaki R; Yamaguchi K; Law P; McMannis JD
Blood; 1998 Nov; 92(9):3123-30. PubMed ID: 9787147
[TBL] [Abstract][Full Text] [Related]
7. CD34
Mainardi C; Ebinger M; Enkel S; Feuchtinger T; Teltschik HM; Eyrich M; Schumm M; Rabsteyn A; Schlegel P; Seitz C; Schwarze CP; Müller I; Greil J; Bader P; Schlegel PG; Martin D; Holzer U; Döring M; Handgretinger R; Lang P
Br J Haematol; 2018 Jan; 180(1):90-99. PubMed ID: 29205259
[TBL] [Abstract][Full Text] [Related]
8. CD34+ selected peripheral blood Stem Cell Boost (SCB) for Poor Graft Function (PGF) or mixed chimerism in pediatric patients, after hematopoietic stem cell transplantation: Results of a retrospective multicenter study.
Berger M; Faraci M; Saglio F; Giardino S; Ernestina Vassallo E; Prete A; Fagioli F
Pediatr Transplant; 2021 Aug; 25(5):e13909. PubMed ID: 33141997
[TBL] [Abstract][Full Text] [Related]
9. Graft Failure Incidence, Risk Factors, and Outcomes in Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.
Mata JR; Zahurak M; Rosen N; DeZern AE; Jones RJ; Ambinder AJ
Transplant Cell Ther; 2024 Jun; 30(6):588-596. PubMed ID: 38521411
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
Körbling M; Huh YO; Durett A; Mirza N; Miller P; Engel H; Anderlini P; van Besien K; Andreeff M; Przepiorka D; Deisseroth AB; Champlin RE
Blood; 1995 Oct; 86(7):2842-8. PubMed ID: 7545476
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic transplantation using CD34
Purev E; Tian X; Aue G; Pantin J; Vo P; Shalabi R; Reger RN; Cook L; Ramos C; Cho E; Worthy T; Khuu H; Stroncek D; Young NS; Childs RW
Br J Haematol; 2017 Mar; 176(6):950-960. PubMed ID: 28169418
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
[TBL] [Abstract][Full Text] [Related]
13. CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies.
Klyuchnikov E; El-Cheikh J; Sputtek A; Lioznov M; Calmels B; Furst S; Chabannon C; Crocchiolo R; Lemarié C; Faucher C; Bacher U; Alchalby H; Stübig T; Wolschke C; Ayuk F; Reckhaus ML; Blaise D; Kröger N
Biol Blood Marrow Transplant; 2014 Mar; 20(3):382-6. PubMed ID: 24321747
[TBL] [Abstract][Full Text] [Related]
14. [The efficacy and safety of recombinant human granulocyte colony stimulating factor primed donor peripheral cell harvest in treatment of poor graft function after allogeneic stem cell transplantation].
Sun YQ; Liu DH; Xu LP; Zhang XH; Liu KY; Huang XJ
Zhonghua Nei Ke Za Zhi; 2013 Sep; 52(9):730-3. PubMed ID: 24314160
[TBL] [Abstract][Full Text] [Related]
15. CD34 Stem Cell Boost in Pediatric Allogeneic Stem Cell Transplant Recipients: A Case Series and Review of Literature.
Bowman S; Stanek J; Bajwa R; Polishchuk V; Abu-Arja R; Rangarajan HG
Clin Hematol Int; 2023 Jun; 5(2-3):155-164. PubMed ID: 37027103
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term responders.
Bittencourt H; Rocha V; Filion A; Ionescu I; Herr AL; Garnier F; Ades L; Esperou H; Devergie A; Ribaud P; Socie G; Gluckman E
Bone Marrow Transplant; 2005 Sep; 36(5):431-5. PubMed ID: 15980881
[TBL] [Abstract][Full Text] [Related]
17. CD34 selected cells for the treatment of poor graft function after allogeneic stem cell transplantation.
Stasia A; Ghiso A; Galaverna F; Raiola AM; Gualandi F; Luchetti S; Pozzi S; Varaldo R; Lamparelli T; Bregante S; Van Lint MT; di Grazia C; Bacigalupo A
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1440-3. PubMed ID: 24862637
[TBL] [Abstract][Full Text] [Related]
18. Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy.
Bensinger WI; Buckner CD; Shannon-Dorcy K; Rowley S; Appelbaum FR; Benyunes M; Clift R; Martin P; Demirer T; Storb R; Lee M; Schiller G
Blood; 1996 Dec; 88(11):4132-8. PubMed ID: 8943847
[TBL] [Abstract][Full Text] [Related]
19. Risk-factor analysis of poor graft function after allogeneic hematopoietic stem cell transplantation.
Xiao Y; Song J; Jiang Z; Li Y; Gao Y; Xu W; Lu Z; Wang Y; Xiao H
Int J Med Sci; 2014; 11(6):652-7. PubMed ID: 24834012
[TBL] [Abstract][Full Text] [Related]
20. [Effects of CD34(+) selected stem cells for the treatment of poor graft function after allogeneic stem cell transplantation].
Fei XH; He JB; Cheng HY; Yin YM; Zhang WJ; Zhang SQ; Wang XC; Wang JB
Zhonghua Xue Ye Xue Za Zhi; 2018 Oct; 39(10):828-832. PubMed ID: 30369204
[No Abstract] [Full Text] [Related]
[Next] [New Search]
